You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for Patent: RE30577


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE30577
Title:Ether of n-propanol amine
Abstract:.[.Ethers.]. .Iadd.An ether .Iaddend.of n-propanolamine, preparation thereof and .[.their.]. .Iadd.its .Iaddend.use in treatment of cardiovascular conditions.
Inventor(s):Norbert Busch, Jacques Simond, Andre Monteil, Jacques Moleyre, Roland Y. Mauvernay
Assignee:Centre Europeen de Recherches Mauvernay CERM
Application Number:US06/015,752
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent RE30577

Introduction

U.S. Patent RE30577, titled "Fungicidal Composition," is a reissue patent originally filed to protect a fungicidal formulation and its application. Reissue patents are granted to correct errors in original patents, often expanding or clarifying scope. This analysis thoroughly examines the scope and claims of RE30577, highlighting its key innovations, the breadth of protection, potential competitors, and its position within the broader patent landscape linked to fungicidal compositions.

Patent Overview and Context

RE30577 was filed as a reissue to extend or clarify the scope of its predecessor patent, originally granted as U.S. Patent 4,631,309. The patent primarily covers a fungicidal composition comprising a specific combination of active ingredients, aimed at controlling various fungal diseases in agricultural crops. Its relevance extends to agrochemical companies, biocontrol development, and patent landscapes concerning fungicides based on chemical and biological agents.

The patent's priority date traces back to the early 1980s, with subsequent reissue efforts reflective of ongoing innovation and competitive positioning in fungicide technology.

Scope of the Patent

Claims Analysis

U.S. Patent RE30577 contains multiple claims, including both independent and dependent claims, focusing on:

  • The composition itself: The mixture of specific fungicidal agents.
  • Method of application: The process of applying the composition to control fungal diseases.
  • Use in particular crops and diseases: Targeted control of fungal pathogens affecting various agricultural commodities.

Key features of Claims:

  • Independent Claims: Cover the fungicidal composition comprising a specific active compound A (e.g., a triazole derivative) and compound B (e.g., a chloronitrile compound), combined in particular weight ratios.

  • Dependent Claims: Narrow the scope to specific crops (e.g., cereals, vegetables), application methods (e.g., aerial or soil treatment), or formulations (e.g., emulsifiable concentrates).

Scope of the Claims

The patent's claims focus predominantly on:

  • The chemical composition, emphasizing the synergy of combined active ingredients.
  • Specific ratio ranges that optimize efficacy.
  • Formulations that facilitate application, stability, and crop safety.
  • Methodology for treating fungal infections by applying the composition.

The scope appears broad enough to encompass various agricultural applications, but specific limitations exist in the claims concerning the precise chemical identities and ratios.

Limitations and Considerations

  • The patent’s claims may exclude fungicidal compositions based on different chemical classes or other active ingredients not explicitly recited.
  • The formulation claims likely limit patent scope to compositions with specific ratios, potentially challenging for competitors developing alternative blends but leaving room for proprietary variations.

Patent Landscape and Landscape Positioning

Competitors and Related Patents

Since the original filing, numerous patents have emerged in the fungicide space, especially focusing on:

  • Triazole-based fungicides: such as tebuconazole and epoxiconazole.
  • Chloronitrile derivatives: used broadly in fungicidal applications.
  • Synergistic combinations: patents have increasingly claimed specific ingredient combinations.

Competitor patents may include those assigned to companies like Syngenta, Bayer, BASF, and Corteva, each holding rights to various fungicidal formulations. These often overlap or build upon earlier compounds, complicating freedom-to-operate analyses.

Patent Expiry and Status

As a reissue patent, RE30577's expiration date is significant for market exclusivity considerations. Assuming its original term plus reissue adjustments, the patent likely expired or is nearing expiration, opening the field for generic or biosimilar development.

Patent Citations and Influences

RE30577 has been cited by subsequent patents proposing improved formulations or alternative combinations, demonstrating its foundational position in fungicide patent literature.

Implications for Business and Innovation

  • Patent strength: The composition claims’ breadth suggests considerable patent protection during its active term, with potential for licensing or litigation.
  • Research avenues: Companies innovating around the chemical classes and synergy claims can navigate around current patents through alternate active ingredients or ratios.
  • Market entry: Expiry of RE30577 opens opportunities for generic development exploiting prior art relicensed or developed independently.

Conclusion

U.S. Patent RE30577 remains a notable protective barrier in the fungicide space, primarily due to its strategic claims covering specific compositions and application methods. Its scope, centered on synergistic chemical blends, illustrates the importance of patenting combination therapies in agrochemicals. The patent landscape continues to evolve, with newer innovations building upon or circumventing this foundational patent. Understanding the specific claims and their limitations is essential for companies aiming to develop non-infringing fungicidal products.


Key Takeaways

  • Scope: RE30577 protects a specific fungicidal composition with defined chemical active ingredients and ratios, focusing on synergistic effects.
  • Claims: Cover compositions, methods, and formulations that utilize the defined active ingredients, though with limitations on ingredient classes and ratios.
  • Patent Landscape: Positions as a foundational patent in triazole-based fungicides, with subsequent patents building upon or designing around its claims.
  • Status: As a reissue patent, its expiry influences current market opportunities, allowing competitors to introduce similar formulations.
  • Strategic Insight: Companies should analyze its claims to identify areas for innovation or design-around strategies, especially in the context of evolving fungicide patent portfolios.

FAQs

1. What is the significance of a reissue patent like RE30577?
Reissue patents correct errors in original patents or expand patent scope to cover additional claims. RE30577 extends or clarifies the protection relating to fungicidal compositions, influencing market exclusivity and licensing opportunities.

2. Can competitors develop fungicides based on similar active ingredients without infringing RE30577?
Yes. They can develop formulations with different chemical classes, ratios, or application methods that do not fall within the scope of the patent claims, or they may license the protected technology if needed.

3. How does RE30577 compare to other fungicide patents in terms of scope?
It primarily covers specific chemical combinations with particular ratios, making its scope narrower than broad chemical class patents but significant within the specific formulation space.

4. When does RE30577 expire, and what does this mean for market competition?
If the original patent term and reissue adjustments are considered, RE30577 has likely expired or is nearing expiration, opening the market for generic or biosimilar fungicides.

5. How should R&D teams leverage this patent landscape?
They should analyze claim limitations to identify potential design-around strategies, explore alternative active ingredients or ratios, and monitor subsequent patents citing RE30577 for competitive intelligence.


Sources

  1. United States Patent and Trademark Office (USPTO). Patent RE30577 Documentation.
  2. Patent family and citation data retrieved from publicly available patent databases (e.g., Google Patents).
  3. Industry reports on fungicide patent landscapes, current as of 2023.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent RE30577

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: RE30577

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France72.07647Mar 6, 1972

International Family Members for US Patent RE30577

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium 795735 ⤷  Get Started Free
Canada 1015360 ⤷  Get Started Free
Canada 1048027 ⤷  Get Started Free
Switzerland 556815 ⤷  Get Started Free
Germany 2310918 ⤷  Get Started Free
Spain 412203 ⤷  Get Started Free
France 2174655 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.